Literature DB >> 23042590

Mesenchymal stem cells contribute to endogenous FVIII:c production.

Chad Sanada1, Chung-Jung Kuo, Evan J Colletti, Melisa Soland, Saloomeh Mokhtari, Mary Ann Knovich, John Owen, Esmail D Zanjani, Christopher D Porada, Graça Almeida-Porada.   

Abstract

Besides the liver, it has been difficult to identify which organ(s) and/or cellular component(s) contribute significantly to the production of human FVIII:c (FVIII). Thus far, only endothelial cells have been shown to constitute a robust extrahepatic source of FVIII, possibly explaining both the diverse presence of FVIII mRNA in the body, and the observed increase in FVIII levels during liver failure. Here, we investigate whether human mesenchymal stem cells (MSC), ubiquitously present in different organs, could also contribute to FVIII production. MSC isolated from human lung, liver, brain, and bone marrow expressed FVIII message as determined by quantitative-RT-PCR. Using an antibody specific for FVIII, confocal microscopy, and umbilical cord-derived endothelial cells (HUVEC) as a negative control, we demonstrated that, in MSC, FVIII protein was not stored in granules; rather, it localized to the perinuclear region. Furthermore, functional FVIII was detected in MSC supernatants and cell lysates by aPTT and chromogenic assays. These results demonstrate that MSC can contribute at low levels to the functional FVIII pool, and advance the understanding of the physiology of FVIII production and secretion.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23042590      PMCID: PMC3954540          DOI: 10.1002/jcp.24247

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  43 in total

1.  Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.

Authors:  Songtao Shi; Stan Gronthos
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

2.  Extrahepatic factor VIII synthesis. Lung transplants in hemophilic dogs.

Authors:  J J Veltkamp; E Asfaou; K van de Torren; J A van der Does; N H van Tilburg; E K Pauwels
Journal:  Transplantation       Date:  1974-07       Impact factor: 4.939

3.  Plasma factor VIII synthesis and control as revealed by canine organ transplantation.

Authors:  W P Webster; C F Zukoski; P Hutchin; R L Reddick; S R Mandel; G D Penick
Journal:  Am J Physiol       Date:  1971-05

Review 4.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.

Authors:  A I Caplan; S P Bruder
Journal:  Trends Mol Med       Date:  2001-06       Impact factor: 11.951

5.  Genetic induction of a releasable pool of factor VIII in human endothelial cells.

Authors:  J B Rosenberg; J S Greengard; R R Montgomery
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

6.  Tissue distribution of factor VIII gene expression in vivo--a closer look.

Authors:  M J Hollestelle; T Thinnes; K Crain; A Stiko; J K Kruijt; T J van Berkel; D J Loskutoff; J A van Mourik
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

7.  Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure.

Authors:  Christopher B Doering; Cassandra D Josephson; Heather N Craddock; Pete Lollar
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

8.  Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism.

Authors:  R J Corrall; R J Webber; B M Frier
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

9.  Factor VIII expression in liver disease.

Authors:  Martine J Hollestelle; Hendrika G M Geertzen; Irene H Straatsburg; Thomas M van Gulik; Jan A van Mourik
Journal:  Thromb Haemost       Date:  2004-02       Impact factor: 5.249

10.  Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart.

Authors:  Judith A Airey; Graça Almeida-Porada; Evan J Colletti; Christopher D Porada; Jason Chamberlain; Matthew Movsesian; John L Sutko; Esmail D Zanjani
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  14 in total

Review 1.  Mesenchymal stem cells: From regeneration to cancer.

Authors:  Peishan Li; Zheng Gong; Leonard D Shultz; Guangwen Ren
Journal:  Pharmacol Ther       Date:  2019-04-16       Impact factor: 12.310

2.  Bone marrow stem-cell therapy for genetic and chronic liver diseases.

Authors:  Veena Kochat; Prakash Baligar; Rakhi Maiwall; Asok Mukhopadhyay
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

3.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

4.  Perivascular stromal cells as a potential reservoir of human cytomegalovirus.

Authors:  M A Soland; L R Keyes; R Bayne; J Moon; C D Porada; S St Jeor; G Almeida-Porada
Journal:  Am J Transplant       Date:  2014-03-04       Impact factor: 8.086

5.  A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.

Authors:  Scot A Fahs; Matthew T Hille; Qizhen Shi; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

6.  Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase.

Authors:  Bo Young Choi; Ok Joon Kim; Sae-Hong Min; Jeong Hyun Jeong; Sang Won Suh; Tae Nyoung Chung
Journal:  Stem Cells Int       Date:  2018-05-02       Impact factor: 5.443

7.  Treatment with platelet lysate induces endothelial differentation of bone marrow mesenchymal stem cells under fluid shear stress.

Authors:  Farshad Homayouni Moghadam; Tahereh Tayebi; Alireza Moradi; Hamid Nadri; Kazem Barzegar; Gilda Eslami
Journal:  EXCLI J       Date:  2014-06-03       Impact factor: 4.068

8.  Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.

Authors:  Veena Kochat; Sumod Kanjirakkuzhiyil; Prakash Baligar; Perumal Nagarajan; Asok Mukhopadhyay
Journal:  Stem Cell Res Ther       Date:  2015-07-08       Impact factor: 6.832

9.  In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs.

Authors:  Yong Wu; Zhiqing Hu; Zhuo Li; Jialun Pang; Mai Feng; Xuyun Hu; Xiaolin Wang; Siyuan Lin-Peng; Bo Liu; Fangping Chen; Lingqian Wu; Desheng Liang
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

10.  Evaluating Interaction of Cord Blood Hematopoietic Stem/Progenitor Cells with Functionally Integrated Three-Dimensional Microenvironments.

Authors:  Saloomeh Mokhtari; Pedro M Baptista; Dipen A Vyas; Charles Jordan Freeman; Emma Moran; Matthew Brovold; Guillermo A Llamazares; Zanneta Lamar; Christopher D Porada; Shay Soker; Graça Almeida-Porada
Journal:  Stem Cells Transl Med       Date:  2018-02-23       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.